Novel Methylation Biomarkers for Colorectal Cancer Prognosis
Colorectal cancer (CRC) comprises the third most common cancer worldwide and the second regarding number of deaths. In order to make a correct and early diagnosis to predict metastasis formation, biomarkers are an important tool. Although there are multiple signaling pathways associated with cancer...
Enregistré dans:
Auteurs principaux: | Alvaro Gutierrez, Hannah Demond, Priscilla Brebi, Carmen Gloria Ili |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ae4d14f15bcc46308b9d6a4cff2a70f9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Colorectal cancer DNA methylation patterns from patients in Manaus, Brazil
par: Almeida,Fabiana Greyce Oliveira, et autres
Publié: (2015) -
Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool
par: Sternschuss Michal, et autres
Publié: (2021) -
Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer
par: Chengwen Zhao, et autres
Publié: (2021) -
Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer
par: Shen,Xiaogang, et autres
Publié: (2017) -
Analysis of core genes for colorectal cancer prognosis based on immune and stromal scores
par: Yi Zhu, et autres
Publié: (2021)